MKI67 and neoplasm: We therefore tested and robustly validated ‘Ki‐67 positivity and lymph node ratio’ (LNR) at the time of the primary tumor surgery as a surrogate predictive and prognostic marker in TNBC, with minor modifications [31, 32, 33] (Fig. S1B).